case_images: PMC11729150_01
case_images: Index change curve. (A) Horizontal line chart of prolactin at different times. (B) Line chart of liver function changes at different times. ALT = alanine aminotransferase, AST = aspartate aminotransferase, DB = direct bilirubin, LDH = lumber disc herniation, TB = total bilirubin.
case_images: medi-104-e41168-g001.jpg
case_images: PMC11729150_01_medi-104-e41168-g001.jpg
case_images: F1
case_images: On July 11, 2023, the patient had a history of taking Chinese medicine, so consider the disease as drug-induced liver injury or HPRL (Tables 1 and 2; Figs. 1-6).
case_images: Abdominal enhanced computed tomography (CT) in July 11, 2020, and abdominal CT plain scan in July 21, 2023.
case_images: medi-104-e41168-g002.jpg
case_images: PMC11729150_01_medi-104-e41168-g002.jpg
case_images: F2
case_images: On July 11, 2023, the patient had a history of taking Chinese medicine, so consider the disease as drug-induced liver injury or HPRL (Tables 1 and 2; Figs. 1-6).
case_images: Upper abdominal magnetic resonance imaging in September 28, 2023: T1-weighted image arterial enhancement stage and T2-weighted image nonarterial enhancement stage.
case_images: medi-104-e41168-g003.jpg
case_images: PMC11729150_01_medi-104-e41168-g003.jpg
case_images: F3
case_images: On July 11, 2023, the patient had a history of taking Chinese medicine, so consider the disease as drug-induced liver injury or HPRL (Tables 1 and 2; Figs. 1-6).
case_images: Upper abdominal magnetic resonance imaging with disodium gadosenate in November 18, 2023: T1-weighted image arterial enhancement phase and T2-weighted image nonarterial enhancement phase.
case_images: medi-104-e41168-g004.jpg
case_images: PMC11729150_01_medi-104-e41168-g004.jpg
case_images: F4
case_images: On July 11, 2023, the patient had a history of taking Chinese medicine, so consider the disease as drug-induced liver injury or HPRL (Tables 1 and 2; Figs. 1-6).
case_images: Liver 4Dflow magnetic resonance imaging in April 20, 2024: arterial enhancement phase on T1-weighted image and nonarterial enhancement phase on T2-weighted image.
case_images: medi-104-e41168-g005.jpg
case_images: PMC11729150_01_medi-104-e41168-g005.jpg
case_images: F5
case_images: On July 11, 2023, the patient had a history of taking Chinese medicine, so consider the disease as drug-induced liver injury or HPRL (Tables 1 and 2; Figs. 1-6).
case_images: Comparison of pituitary magnetic resonance imaging enhancement between in October 1, 2023, and January 19, 2024.
case_images: medi-104-e41168-g006.jpg
case_images: PMC11729150_01_medi-104-e41168-g006.jpg
case_images: F6
case_images: On July 11, 2023, the patient had a history of taking Chinese medicine, so consider the disease as drug-induced liver injury or HPRL (Tables 1 and 2; Figs. 1-6).